Recent trials show no significant difference in smoking cessation rates between e-cigarettes and combination nicotine replacement therapy among patients discharged from inpatient substance use withdrawal services. Longitudinal analyses reveal variable abstinence trajectories in e-cigarette trials, underscoring the need for further relapse-focused research.